Clinical trial
Arterial Closure Device Comparison Trial II - ACDC Trial II
NCT00428155 · Unity Health Toronto, Other · Unknown status
Key facts
| NCT number | NCT00428155 |
|---|---|
| Title | Arterial Closure Device Comparison Trial II - ACDC Trial II |
| Official title | A Randomized Trial of Angioseal and Starclose for Hemostasis After PCI |
| Lead sponsor | Unity Health Toronto, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Arterial Hemostasis After Coronary Intervention |
| Intervention type | Device |
| Interventions | closure device placement |
| Enrollment | 448 |
| Start date | Jan 1, 2007 |
| First posted | Jan 29, 2007 |
| Last update posted | Jan 29, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: